ID | 169 |
No | 169 |
Brand Name | LANZAAR 100 |
Ingredients | LOSARTAN POTASSIUM 100 MG |
Dosage Form | FILM COATED TABLET |
Primary Packaging | ALU-PVDC |
Storage | STORE BELOW 30'C |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 3 X 10'S |
Dispensing Category | Prescription only |
ATC Classification | C09CA01 |
Pharmaceutical Class | ANTIHYPERTENSIVE |
Indications | - TREATMENT OF HYPERTENSION (HTN), DIABETIC NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS( NIDDM) AND A HISTORY OF HYPERTENSION
- STROKE RISK REDUCTION IN PATIENTS WITH HTN AND LEFT VENTRICULAR HYPERTROPHY" |
Contraindications | "- HYPERSENSITIVITY TO OTHER ANGIOTENSIN II RECEPTOR ANTAGONISTS
- BILATERAL RENAL ARTERY STENOSIS - PREGNANCY ( 2 ND AND 3RD TRIMESTERS)" |
Side Effects | > 10% : CHEST PAIN, FATIGUE, HYPOGLYCEMIA, DIARRHEA, URINARY TRACT INFECTION, ANEMIA, WEAKNESS, BACK PAIN, COUGH 1% TO 10%
|
Unit Price | |
EDL |
Yes |
Description | WHITE OVAL BICONVEX FILM COATED TABLETS WITH ''BERLIN'' ON ONE SIDE AND SCORED BETWEEN L AND 100 ON THE OTHER SIDE |
Note | |
License Owner | BERLIN PHARMA LAO CO.,LTD |
Manufacturer | BERLIN PHARMACEUTICAL INDUSTRY CO.,LTD |
Country | THAILAND |
Import Registration No | 1A 3/58(NG) |
Import Registration Date | 2015-05-25 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2023-10-13 |
FDD Registration No | 02 I 5044/21 |
FDD Registration Date | 2023-11-23 |
Expiry Date | 2026-11-22 |